Discussion 8: Redefining the Role of Industry in Contemporary Healthcare

Cliff Goodman, PhD; John L. Fox, MD, MHA; Bo Gamble

The final panel of the conference analyzes the role of the industry in healthcare, including panelists’ observations on topics such as innovation. Mr Gamble, for instance, offers his insights as to how groups like the Community Oncology Alliance are working with the industry to “drive the message about the quality and the value component throughout all the stakeholders.” Dr Fox provides perspective on how payers can offer valuable partnerships throughout the industry, including those with pharmaceutical companies.

Bo Gamble says, “That’s our focus on anything that we do, and whether that drug is 10 years out or whether it’s going to be 3 years out or next year, look at not only the quality of the drug, but also the value that you bring. We’ve got to bring the cost of cancer care down while also raising the quality. That’s what the patient is demanding. That’s what payers are demanding. That’s what CMS is demanding. That’s what everybody wants. We’ve got to figure out how to make it happen. It’s a process, not an event.”

Print | AJMC Printing...